About Aver Pharmaceuticals Private Limited
Data last updated:
Aver Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 May 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2009PTC190494. Its GSTIN is 07AAHCA7176R1ZV (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashish Bhatia and Sachin Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 355 3rd Floor Blue Star Plaza Sarja Market Naharpur Rohini Sector 7, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.58 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹57,460 (net margin 1.1%) and EBITDA of ₹94,794 (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹37 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website averpharma.com.
Company details
Contact details
Aver Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is averpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address355 3rd Floor Blue Star Plaza Sarja Market Naharpur Rohini Sector 7, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aver Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aver Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aver Pharmaceuticals Private Limited, buy the company report.
Financials of Aver Pharmaceuticals Private Limited
FY 2025 filings availableAver Pharmaceuticals Private Limited reported revenue of ₹54.58 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94,794 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57,460 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aver Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aver Pharmaceuticals Private Limited
Aver Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Bhatia Also directs: Medgroc LLP, Tomorrowland Global Trips Private Limited | Director | 21 May 2009 | 17 Years 5 Months | Current |
| Sachin Bhatia | Director | 21 May 2009 | 17 Years 5 Months | Current |
| Guneet Bhatia | Director | 27 Feb 2014 | 12 Years 8 Months | Current |
| Aman Dudeja Also directs: Biogold Pharmaceutical Private Limited | Director | 05 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Aver Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mebio Labs Private Limited | ₹54.64 Lakh (FY 2025) | -11.0% | Mumbai, Maharashtra, India | |||
| Aver Pharmaceuticals Private Limitedthis company | ₹54.58 Lakh (FY 2025) | ₹57,460 | 1.1% | 3.0% | Delhi, India | |
| Lamium Pharmaceuticals Private Limited | ₹54.41 Lakh (FY 2025) | -17.0% | Pune, Maharashtra, India | |||
| SLB Healthcare Private Limited | ₹54.38 Lakh (FY 2025) | 8.0% | Panchkula, Haryana, India |
To see the full peer comparison of Aver Pharmaceuticals Private Limited, buy the company report.
Auditor
Aver Pharmaceuticals Private Limited is audited by MANIKTALIYA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANIKTALIYA & CO | FY 2018 | 016136N |
Shareholding
The shareholding of Aver Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aver Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Apr 2014 | 10494605 | Punjab National Bank | ₹37 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Aver Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Aver Pharmaceuticals, 1 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by Pushkar Pharma | Pending |
| District court, North West, Delhi | Criminal case | Filed by the company against Prudent Pharmaceuticals and Anothers and 2 others | Disposed |
To see the full case history of Aver Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aver Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aver Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCA7176R1ZV | Delhi | Active | 01 Jul 2017 |
| 03AAHCA7176R1Z3 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aver Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aver Pharmaceuticals Private Limited has 5 board changes on record since 2009: 4 appointments and 1 cessation. The latest: Sachin Bhatia ceased to be Director on 31 Jan 2021.
Frequently asked questions
Aver Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 May 2009 (17+ years old) and is registered under CIN U24232DL2009PTC190494.
Aver Pharmaceuticals has 4 current directors:
- Ashish Bhatia - Director
- Sachin Bhatia - Director
- Guneet Bhatia - Director
- Aman Dudeja - Director
The latest financial statements of Aver Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aver Pharmaceuticals is 07AAHCA7176R1ZV, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 03AAHCA7176R1Z3 (Punjab).
The CIN (Corporate Identification Number) of Aver Pharmaceuticals is U24232DL2009PTC190494. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aver Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.
Aver Pharmaceuticals was incorporated on 21 May 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aver Pharmaceuticals by revenue are Mebio Labs Private Limited, Lamium Pharmaceuticals Private Limited, SLB Healthcare Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (retail trading).
Sachin Bhatia ceased to be Director on 31 Jan 2021. Aman Dudeja was appointed as Director on 05 Dec 2018. Guneet Bhatia was appointed as Director on 27 Feb 2014. Aver Pharmaceuticals has 5 board changes on record in total.
Aver Pharmaceuticals can be reached through the website averpharma.com. Its registered office is in Delhi, India.
The registered office of Aver Pharmaceuticals is at 355 3rd Floor Blue Star Plaza Sarja Market Naharpur Rohini Sector 7, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
